| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8522675 | Saudi Pharmaceutical Journal | 2017 | 5 Pages |
Abstract
Liver functions were not affected as there is no effect on the activity of both AST and ALT in animals that received the compounds, so the compounds didn't reveal hepatotoxic manifestation. Although, the results on kidney functions showed that, CP-1 slightly elevated blood urea concentration and CP-3 & CP-4 slightly elevated serum creatinine; no apparent nephrotoxic manifestations were recorded.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Amani S. Awaad, Ahmed M. Alafeefy, Fatmah A.S. Alasmary, Reham M. El-Meligy, Saleh I. Alqasoumi,